Objective
Our proposal is to create new nanomedicines for identifying anti-inflammatory therapies. Through the optimisation of synthetic procedures, we aim to control the primary sequence of the polymer, the size of the nanomedicine, and degradation profiles. High-content in vitro screening will be utilised to determine which formulations can most selectively target macrophages and have the strongest anti-inflammatory effect. To test the effectiveness of these formulations, we will collaborate with specialised research groups to conduct appropriate in vivo testing using various models of inflammation.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- natural scienceschemical sciencespolymer sciences
- medical and health sciencesmedical biotechnologynanomedicine
You need to log in or register to use this function
Programme(s)
- HORIZON.1.1 - European Research Council (ERC) Main Programme
Funding Scheme
HORIZON-ERC-POC - HORIZON ERC Proof of Concept GrantsHost institution
08028 Barcelona
Spain